NATRIUM DIKLOFENAK UNTUK PENGOBATAN NOKTURIA YANG DISEBABKAN OLEH NOCTURNAL POLYURIA

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Eddy Sunarno Sabilal Alif Sunaryo Hardjowijoto Widodo J P

Abstract

Objective: To investigate the efficacy of diclofenac 50 mg (Non-Steroidal Anti-Inflammatory Drug) in the treatment of nocturnal polyuria. Materials and methods: Twenty four patients (23 male and 1 female) with a mean age of 61 years (range 34 – 80) diagnosed with nocturnal polyuria were recruited. The study period comprised 2 weeks of either placebo or active medication. Following one-week rest period, patients were crossed over to the other medication for a further 2 weeks. Frequency volume charts were completed during the second week of each of the two study periods along with feedback forms to assess any subjective improvement in symptoms during each of the study periods. Results: A significant improvement in the symptoms was noted for diclofenac when compared with the placebo. The mean nocturnal frequency decreased from 3,61 ± 2,45 to 2,39 ± 1,1 (p<0,05) and the mean 24 h urine volume decreased from 1139,64 ± 365 to 1089 ± 324 (p>0,05), but there is no statistically different. No significant side effects were reported. Conclusion: Natrium diclofenac 50 mg are effective in the treatment of nocturnal polyuria causing a decrease in nocturnal frequency with subjective symptom improvement. Our study suggests, Natrium diclofenac not to prolonged treatment. Further research to find the alternative treatment is recommended.


##plugins.themes.bootstrap3.article.details##

Keywords

Natrium diclofenac, nocturia

References

Abrams. Nocturia: The major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). European Urology Supplements 2005; 3: 8-16.

Van Kerrebroeck, Weiss JP. Standardization and terminology of nocturia. British Journal of Urology International 1999; 84: 1-4.

Weiss JP, Blaivas JG. Nocturia. The Journal of Urology 2000; 163: 5-12.

Tohru Araki, Yokohama T, Kumon H. Effectiveness of nonsteroidal anti inflammatory drug for nocturia on patient with benign prostatic hyperplasia: A prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Medica Okayama. 2004; 58 (1): 45-9.

Sanjai Addla, Adebanjib Adeyoju, Donald Neilson, Patrick O’reilly. Diclofenac for terapi of nocturia caused by nocturnal polyuria: A prospective, randommised, double-blind, placebo-controlled crossover study. European Urology 2006; 49: 720-6.

Asplund. Mortality in the elderly in relation to nokturnal micturition. BJU International 1999; 84: 297-301.

Du Beau CE, Yall SV, Resnick N. Implication of the most bothersome prostatism symptoms for clinical care & outcome research. Journal American Geriatric Society 1995; 43: 985.

Paick, Ku JH, Shin JW, Yanhg JH, Kim SW. Alpha blocker monotherapy in the terapy of nocturia in men with lower urinary tract symptoms: A prospective study of response prediction. BJU International 2006; 978: 1017-23.

Saito Maroto, Sato Miyagawa, Kawatani. Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia. International Journal of Urology 2005; 12: 778-9.

Al-Waili NS. Indometacin suppositories: An alternative terapi for nocturnal frequency of micturition. IRCS Med Sci. 1986; 14: 322-3.

Le Fanu J. The value of aspirin in controlling the symptoms of nocturnal polyuria. BJU International 2001; 88: 126-7.

Kirkland JL, Lye M, Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 1983; 287: 1665-7.

Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol; 1989. p. 256-71.

Robertson GL, Norgaard JP. Renal regulation of urine volume: Potential implications for nocturia. BJU International 2002; 3: 7-10.

Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229: 131-4.

Dilger K, Herrlinger C, Peters J, Seyberth HW, Schweer H, Klotz U. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects. J Clin Pharmacol 2002; 42: 985-94.

Kinn AC, Elbarouni J, Seideman P, Sollevi A. The effect of diclofenac sodium on renal function. Scand J Urol Nephrol 1989; 23: 153-7.

Section
Articles
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University